HP0664
LD 951
Session - 126th Maine Legislature
C "A", Filing Number H-559, Sponsored by
LR 1577
Item 2
Bill Tracking, Additional Documents Chamber Status

Amend the bill by striking out the title and substituting the following:

‘An Act To Amend the Prior Authorization Process for Methadone and Suboxone Treatments under MaineCare’

Amend the bill by striking out everything after the enacting clause and before the summary and inserting the following:

Sec. 1. 22 MRSA §3174-SS, sub-§1,  as enacted by PL 2011, c. 477, Pt. I, §1, is repealed and the following enacted in its place:

1 Twenty-four month limit.   Beginning January 1, 2013, reimbursement under the MaineCare program for buprenorphine and naloxone combination drugs for the treatment of addiction to opioids is limited to a total of 24 months except that coverage must be provided beyond 24 months if one or more of the following apply:
A The individual is pregnant, has a serious and persistent mental illness or resides with a child under 3 years of age for whom the individual is primarily responsible;
B The individual is taking a daily maintenance amount of 4 milligrams or less; or
C The department gives prior authorization for coverage.

The 24-month limit includes months prior to January 1, 2013 for which the individual received coverage.

The department shall adopt rules to implement this subsection. Rules adopted pursuant to this subsection are routine technical rules as defined by Title 5, chapter 375, subchapter 2-A.

Sec. 2. 22 MRSA §3174-VV,  as reallocated by RR 2011, c. 2, §27, is repealed and the following enacted in its place:

§ 3174-VV Methadone reimbursement limitations

1 Twenty-four month limit.   Effective January 1, 2013, reimbursement under the MaineCare program for methadone for the treatment of addiction to opioids is limited to a lifetime maximum of 24 months, except that coverage must be provided beyond 24 months if one of the following apply:
A The individual is pregnant, has a serious and persistent mental illness or resides with a child under 3 years of age for whom the individual is primarily responsible;
B The individual is taking an adequate daily amount that is considered to be a maintenance amount; or
C The department gives prior authorization for coverage.
2 Rulemaking.   The department shall adopt rules to implement this section. Rules adopted pursuant to this subsection are routine technical rules as defined by Title 5, chapter 375, subchapter 2-A. The rules must include a determination of an amount considered a maintenance amount pursuant to subsection 1, paragraph B.

Sec. 3. Department of Health and Human Services to increase MaineCare reimbursement rates. The Department of Health and Human Services shall amend its MaineCare rules regarding reimbursement rates paid to methadone clinics to increase the rate from $60 a week to $70 a week beginning October 1, 2013.

Sec. 4. Appropriations and allocations. The following appropriations and allocations are made.

HEALTH AND HUMAN SERVICES, DEPARTMENT OF (FORMERLY BDS)

Mental Health Services - Community Medicaid 0732

Initiative: Provides funds to allow MaineCare reimbursement for methadone for the treatment of addiction to opioids under certain conditions.

GENERAL FUND 2013-14 2014-15
All Other
$0 $208,848
inline graphic sline.gif inline graphic sline.gif
GENERAL FUND TOTAL $0 $208,848

Office of Substance Abuse - Medicaid Seed 0844

Initiative: Provides funds to allow MaineCare reimbursement for methadone for the treatment of addiction to opioids under certain conditions.

GENERAL FUND 2013-14 2014-15
All Other
$0 $60,237
inline graphic sline.gif inline graphic sline.gif
GENERAL FUND TOTAL $0 $60,237

HEALTH AND HUMAN SERVICES, DEPARTMENT OF (FORMERLY BDS)
DEPARTMENT TOTALS 2013-14 2014-15
GENERAL FUND
$0 $269,085
inline graphic sline.gif inline graphic sline.gif
DEPARTMENT TOTAL - ALL FUNDS $0 $269,085

HEALTH AND HUMAN SERVICES, DEPARTMENT OF (FORMERLY DHS)

Medical Care - Payments to Providers 0147

Initiative: Provides funds to allow MaineCare reimbursement for buprenorphine and naloxone combination drugs for the treatment of addiction to opioids under certain conditions.

GENERAL FUND 2013-14 2014-15
All Other
$207,956 $209,345
inline graphic sline.gif inline graphic sline.gif
GENERAL FUND TOTAL $207,956 $209,345

FEDERAL EXPENDITURES FUND 2013-14 2014-15
All Other
$336,503 $335,115
inline graphic sline.gif inline graphic sline.gif
FEDERAL EXPENDITURES FUND TOTAL $336,503 $335,115

Medical Care - Payments to Providers 0147

Initiative: Provides funds to allow MaineCare reimbursement for methadone for the treatment of addiction to opioids under certain conditions.

GENERAL FUND 2013-14 2014-15
All Other
$0 $329,342
inline graphic sline.gif inline graphic sline.gif
GENERAL FUND TOTAL $0 $329,342

FEDERAL EXPENDITURES FUND 2013-14 2014-15
All Other
$0 $957,949
inline graphic sline.gif inline graphic sline.gif
FEDERAL EXPENDITURES FUND TOTAL $0 $957,949

HEALTH AND HUMAN SERVICES, DEPARTMENT OF (FORMERLY DHS)
DEPARTMENT TOTALS 2013-14 2014-15
GENERAL FUND
$207,956 $538,687
FEDERAL EXPENDITURES FUND
$336,503 $1,293,064
inline graphic sline.gif inline graphic sline.gif
DEPARTMENT TOTAL - ALL FUNDS $544,459 $1,831,751

SECTION TOTALS 2013-14 2014-15
GENERAL FUND
$207,956 $807,772
FEDERAL EXPENDITURES FUND
$336,503 $1,293,064
inline graphic sline.gif inline graphic sline.gif
SECTION TOTAL - ALL FUNDS $544,459 $2,100,836

Sec. 5. Appropriations and allocations. The following appropriations and allocations are made.

HEALTH AND HUMAN SERVICES, DEPARTMENT OF (FORMERLY DHS)

Medical Care - Payments to Providers 0147

Initiative: Provides funds to increase reimbursement rates paid to methadone clinics from $60 a week to $70 a week beginning October 1, 2013.

GENERAL FUND 2013-14 2014-15
All Other
$370,383 $497,141
inline graphic sline.gif inline graphic sline.gif
GENERAL FUND TOTAL $370,383 $497,141

FEDERAL EXPENDITURES FUND 2013-14 2014-15
All Other
$599,333 $795,813
inline graphic sline.gif inline graphic sline.gif
FEDERAL EXPENDITURES FUND TOTAL $599,333 $795,813

summary

This amendment replaces the bill and is the majority report of the committee. The amendment amends the prior authorization process for methadone and so-called Suboxone treatments under MaineCare. It allows for the continuation of coverage, without prior authorization, if the individual receiving the treatment is pregnant, has serious and persistent mental illness or resides with a child under 3 years of age for whom the individual is primarily responsible. It also allows an individual who is on a low daily dose that is considered a maintenance dose to continue coverage without prior authorization. For Suboxone, this amount is 4 milligrams. The maintenance dose for methadone will be determined in the Department of Health and Human Services rules. The amendment also directs the department to increase the reimbursement rates paid to methadone clinics from $60 a week to $70 a week.

FISCAL NOTE REQUIRED
(See attached)


Top of Page